Loading...
DexCom Community
NasdaqGS:DXCM Community- 1 Narratives written by author
- 1 Comments on narratives written by author
- 118 Fair Values set on narratives written by author
Community Investing Ideas
DXCM: Expanding Reimbursement Will Drive Gains Despite Market Uncertainty
Key Takeaways Expanded reimbursement and international coverage unlock new patient segments, fueling sustained revenue growth while diversifying global revenue streams. Advances in product innovation, digital integration, and operational efficiencies drive higher margins, recurring revenues, and increased patient loyalty.Read more
0users have liked this narrative
1users have commented on this narrative
60users have followed this narrative
AN
US$98.4
44.1% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
14.67% p.a.
Profit Margin
21.46%
Future PE
34.93x
Share price in 2028
US$122.5